Targeted PLGA-Microparticles as a Novel Concept for Treatment of Lactose Intolerance

X. WANG; G. RATZINGER; M. WIRTH; F. GABOR

doi:10.3797/scipharm.cespt.8.LDD05

You are currently viewing a new version of our website. To view the old version click .

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).

Conference Report

12 July 2010

Targeted PLGA-Microparticles as a Novel Concept for Treatment of Lactose Intolerance

and

Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Life Sciences, University of Vienna, Vienna, Austria

Author to whom correspondence should be addressed.

These authors equally contributed to this work.

Sci. Pharm.2010, 78(3), 559;https://doi.org/10.3797/scipharm.cespt.8.LDD05

Version Notes

Order Reprints

Abstract

Background: Lactose intolerance is the inability to metabolize lactose because of the absence of the enzyme lactase. It is estimated that 75–90% of birth lactase levels are lost by most people after weaning. [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

New Hierarchically Organized Systems for Delivery

Delivering of Resveratrol with Solid Lipid Nanoparticles Improved Mitochondria Activity